Kevin Kotler - Feb 22, 2023 Form 3 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role: Director
Signature: /s/ Lisa Peraza Attorney-in-fact for Kevin Kotler
Stock symbol: HRTX
Transactions as of: Feb 22, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/2/2023, 03:13 PM
Previous filing: Mar 22, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HRTX	Common Stock						37.9K	Feb 22, 2023	Direct	F1
holding	HRTX	Common Stock						540K	Feb 22, 2023	By Broadfin Holdings LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HRTX	Stock Option (Right to Buy)							Feb 22, 2023	Common Stock	227K	$2.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (02/22/2023).
F2	The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023).